tradingkey.logo
tradingkey.logo
Search

Purple Biotech Ltd

PPBT
Add to Watchlist
1.400USD
-0.010-0.71%
Close 07-31 16:00ETQuotes delayed by 15 min
13.01MMarket Cap
LossP/E TTM

PPBT Financials

See Purple Biotech Ltd's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Purple Biotech Ltd Earnings Date

Latest Release
May 15, 2026
EPS / Forecast
--/-0.38
Revenue / Forecast
--/--
Period
FY2025 Earnings
Revenue(YoY)
--
--
EPS(YoY)
-5.50
-24.46%
Analyst Rating
BUY
2026/07/31
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
FY2020H2
FY2020H1
FY2019H2
Financial Indicators
EPS
94.19%-0.01
-1414.29%-2.54
42.34%-0.29
77.95%-0.40
93.80%-0.17
93.34%-0.17
89.25%-0.50
63.29%-1.80
43.55%-2.78
61.38%-2.52
---4.61
---4.89
---4.92
---6.54
---0.09
----
----
----
----
----
----
----
----
Net Profit
81.02%-86.00K
-5642.68%-23.55M
-96.53%-1.30M
54.89%-1.08M
87.96%-453.00K
91.51%-410.00K
86.83%-663.00K
53.19%-2.41M
22.88%-3.76M
19.68%-4.83M
-4.39%-5.04M
-45.31%-5.14M
33.15%-4.88M
-18.54%-6.01M
-53.78%-4.82M
2.54%-3.54M
-11.46%-7.30M
---5.07M
---3.14M
---3.63M
----
----
----
Debt to assets ratio
231.58%1.28%
181.04%1.39%
3.64%0.66%
-58.60%0.30%
-50.02%0.38%
-37.64%0.49%
-22.62%0.63%
-17.49%0.72%
-12.46%0.77%
-15.97%0.79%
--0.82%
--0.88%
--0.88%
--0.94%
--0.94%
----
----
----
----
----
----
----
----
Operating profit
-60.10%-2.25M
-191.63%-2.96M
35.91%-1.37M
62.04%-1.24M
68.52%-1.41M
83.79%-1.02M
62.88%-2.13M
36.59%-3.26M
12.81%-4.47M
5.06%-6.27M
-13.11%-5.75M
-43.04%-5.13M
30.13%-5.12M
-48.30%-6.60M
-67.03%-5.08M
0.88%-3.59M
-12.25%-7.33M
---4.45M
---3.04M
---3.62M
----
----
----
Net Profit
81.02%-86.00K
-5642.68%-23.55M
-96.53%-1.30M
54.89%-1.08M
87.96%-453.00K
91.51%-410.00K
86.83%-663.00K
53.19%-2.41M
22.88%-3.76M
19.68%-4.83M
-4.39%-5.04M
-45.31%-5.14M
33.15%-4.88M
-18.54%-6.01M
-53.78%-4.82M
2.54%-3.54M
-11.46%-7.30M
---5.07M
---3.14M
---3.63M
----
----
----
Current assets
-9.79%6.78M
10.75%9.87M
55.29%10.77M
-19.72%6.31M
-34.09%7.51M
-43.58%8.91M
-58.50%6.94M
-59.43%7.86M
-53.29%11.40M
-52.53%15.79M
-51.27%16.72M
-48.24%19.38M
-41.74%24.41M
-31.39%33.26M
-27.31%34.31M
-25.11%37.45M
-27.06%41.90M
--48.47M
--47.20M
--50.00M
----
----
----
Total current liabilities
66.53%4.59M
94.46%7.75M
10.95%6.06M
-66.16%2.19M
-67.59%2.76M
-44.49%3.99M
-12.23%5.46M
32.65%6.47M
51.50%8.51M
1.77%7.18M
4.84%6.22M
-9.60%4.88M
-21.86%5.62M
66.07%7.06M
73.18%5.93M
54.25%5.39M
20.34%7.19M
--4.25M
--3.43M
--3.50M
----
----
----
Total assets
-59.50%14.42M
-52.56%17.57M
11.27%39.06M
-4.68%34.38M
-10.71%35.59M
-16.40%37.04M
-22.46%35.10M
-24.86%36.06M
-24.90%39.86M
-18.89%44.30M
-22.67%45.27M
-22.26%48.00M
-19.93%53.08M
-22.19%54.62M
-20.49%58.54M
-19.28%61.74M
-19.11%66.29M
--70.20M
--73.63M
--76.49M
----
----
----
Total liabilities
64.01%4.75M
91.74%7.91M
10.78%6.25M
-65.18%2.33M
-66.96%2.90M
-58.75%4.13M
-13.96%5.64M
27.29%6.69M
45.33%8.77M
32.97%10.01M
1.87%6.55M
-13.66%5.25M
-24.31%6.04M
47.76%7.52M
51.22%6.43M
39.34%6.08M
16.25%7.97M
--5.09M
--4.25M
--4.37M
----
----
----
Total equity
-70.44%9.66M
-70.65%9.66M
11.36%32.81M
9.10%32.05M
5.16%32.70M
-4.04%32.91M
-23.90%29.47M
-31.27%29.38M
-33.91%31.09M
-27.18%34.30M
-25.70%38.72M
-23.20%42.74M
-19.33%47.05M
-27.66%47.10M
-24.89%52.11M
-22.83%55.66M
-22.34%58.32M
--65.11M
--69.37M
--72.12M
----
----
----
Net operating income
-57.74%-3.08M
48.24%-1.03M
68.93%-1.00M
61.37%-1.51M
60.71%-1.95M
59.56%-1.99M
8.78%-3.23M
22.57%-3.90M
13.24%-4.97M
-16.16%-4.92M
-2.49%-3.54M
-36.05%-5.04M
-12.63%-5.73M
---4.23M
---3.46M
---3.71M
---5.08M
----
----
----
-183.96%-9.10M
-104.66%-4.61M
37.07%-3.20M
Net investment
-100.90%-2.00K
---156.00K
10866.67%323.00K
1060.00%58.00K
18.18%221.00K
100.00%0.00
-100.34%-3.00K
150.00%5.00K
-98.47%187.00K
-100.08%-6.00K
22075.00%879.00K
100.03%2.00K
-30.32%12.25M
--8.00M
---4.00K
---5.99M
--17.58M
----
----
----
-1114.14%-49.77M
101.25%69.00K
-2.17%4.91M
Net financing
-152.21%-59.00K
-92.13%311.00K
158.88%5.55M
-14.45%379.00K
-59.50%113.00K
-7.25%3.95M
266.67%2.15M
15.97%443.00K
0.36%279.00K
3881.31%4.26M
0.00%585.00K
23.23%382.00K
55.31%278.00K
--107.00K
--585.00K
--310.00K
--179.00K
----
----
----
6617.07%5.34M
1082.26%63.17M
---82.00K

FAQs

What are the current assets of Purple Biotech Ltd?

According to Purple Biotech Ltd's FY2025 earnings report, its current assets were 9.87M, with a year-on-year change of 10.75.

What are the total assets of Purple Biotech Ltd?

According to Purple Biotech Ltd's FY2025 earnings report, its total assets of Purple Biotech Ltd were 17.57M, with a year-on-year change of -52.56.

What are the total liabilities of Purple Biotech Ltd?

According to Purple Biotech Ltd's FY2025 earnings report, its total liabilities of Purple Biotech Ltd were 7.91M, with a year-on-year change of 91.74.

What is the total equity of Purple Biotech Ltd?

According to Purple Biotech Ltd's FY2025 earnings report, its total equity of Purple Biotech Ltd was 9.66M, with a year-on-year change of -70.65.

What is the net operating income of Purple Biotech Ltd?

According to Purple Biotech Ltd's FY2025 earnings report, its net operating income of Purple Biotech Ltd was -6.98M, with a year-on-year change of 35.43.

What is the net investment of Purple Biotech Ltd?

According to Purple Biotech Ltd's FY2025 earnings report, its net investment of Purple Biotech Ltd was 446.00K, with a year-on-year change of 135.98.

What is the net financing of Purple Biotech Ltd?

According to Purple Biotech Ltd's FY2025 earnings report, its net financing of Purple Biotech Ltd was 6.36M, with a year-on-year change of -6.78.

What is the Earnings Per Share (EPS) of Purple Biotech Ltd?

According to Purple Biotech Ltd's FY2025 earnings report, its Earnings Per Share (EPS) was -5.50, with a year-on-year change of -24.46.

What is the net income of Purple Biotech Ltd?

According to Purple Biotech Ltd's FY2025 earnings report, its net income was -26.39M, with a year-on-year change of -264.45.

What is the debt-to-asset ratio of Purple Biotech Ltd?

According to Purple Biotech Ltd's FY2025 earnings report, its debt-to-asset ratio was 1.39, with a year-on-year change of 181.04.

What is the Return on Equity (ROE) of Purple Biotech Ltd?

According to Purple Biotech Ltd's FY2025 earnings report, its Return on Equity (ROE) was -123.95, with a year-on-year change of -474.12.

What is the Return on Assets (ROA) of Purple Biotech Ltd?

According to Purple Biotech Ltd's FY2025 earnings report, its Return on Assets (ROA) was -97.02, with a year-on-year change of -442.09.

What is the operating profit of Purple Biotech Ltd?

According to Purple Biotech Ltd's FY2025 earnings report, its operating profit was -6.98M, with a year-on-year change of 35.43.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.